|
Cytomatrix
|
Engineering a Thymus for Efficient Production and Study of Murine T Cell Development in a Thymic Organoid |
|||
|
Deborah J. Marshall, James Bagley, Michael Rosenzweig
Immunotherapy, Cytomatrix, Woburn, MA, 01801 |
||||
Fetal thymic organ cultures (FTOC) have been used extensively as the sole source to study thymopoiesis ex vivo. The manufacture of T lymphocytes in vitro has proven problematic in part because of the obligate requirement that T cell generation is dependent on three-dimensional (3-D) interactions with thymic stromal cells. We have developed a novel artificial thymus culture system comprised of a stroma covered, three-dimensional, bio-compatible Cytomatrix™ cell growth matrix. We have previously demonstrated that the Cytomatrix™ provided the obligate three dimensionality required for T cell differentiation; sustained the long-term growth of both murine thymic stromal cells and human hematopoietic stem cells (HSC); and fostered the natural differentiation of T cells in the absence of exogenous factors (i.e. cytokines or serum). We are using this ex vivo culture system to generate T cells from hematopoietic progenitor cells isolated from murine thymus (Sca+Lin-) to induce the differentiation of HSC to functional T cells as a tool to understand the steps involved in thymopoiesis and central tolerance. Briefly, murine thymus was cultured in the Cytomatrix for 2 weeks. Sca+Lin- cells isolated from 4-6 week old murine thymocytes were then co-cultured on the stroma in the absence or presence of cytokines for an additional two weeks. FACS analysis demonstrated the development of CD4+CD8+ double positive as well as CD4+ and CD8+ single positive T cells, the majority of which were CD45RA+ (naive) and TCRab+. In addition, we have been able to demonstrate the maintenance of negative selection events to a superantigen (SEB) and the maintenance of positive and negative selection events to peptides using transgenic mouse models and peptide antigens within this microenvironment. |
||||